P. Ertl

发表

Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: role of the C terminus in antibody reactivity and enzyme function

B. Larder, K. Powell, G. Darby, 1988, Journal of virology.

Fed batch culture with declining specific growth rate for high-yielding production of a plasmid containing a gene therapy sequence in Escherichia coli DH1

A. Rozkov, C. Avignone-Rossa, M. Bushell, 2006 .

Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses

W. Snowden, W. Alderton, P. Ertl, 1995, Antimicrobial agents and chemotherapy.

Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells

K. Powell, P. Ertl, 1992, Journal of virology.

High level expression of DNA polymerases from herpesviruses.

K. Powell, M. Thomas, P. Ertl, 1991, The Journal of general virology.

Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.

J. Heeney, B. Wahrén, G. Engström, 2007, Vaccine.

Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies

R. D. de Wildt, Kathrine J. Smith, J. Yates, 2020, mAbs.

A Comparative Study of the in vitro and in vivo Antiviral Activities of Acyclovir and Penciclovir

W. Miller, W. Snowden, P. Collins, 1995 .

Review of research leading to new anti‐herpesvirus agents in clinical development: Valaciclovir hydrochloride (256u, the L‐valyl ester of acyclovir) and 882c, a specific agent for varicella zoster virus

G. Darby, L. Beauchamp, S. Lacey, 1993, Journal of medical virology.

Characterization of the metabolic burden on Escherichia coli DH1 cells imposed by the presence of a plasmid containing a gene therapy sequence.

A. Rozkov, C. Avignone-Rossa, M. Bushell, 2004, Biotechnology and bioengineering.

Therapeutic DNA Vaccine Induces Broad T Cell Responses in the Gut and Sustained Protection from Viral Rebound and AIDS in SIV-Infected Rhesus Macaques

D. Fuller, M. Murphey-Corb, P. Rajakumar, 2012, PloS one.

Humoral immune response to human cytomegalovirus DNA polymerase

T. Lazzarotto, M. Landini, P. Ertl, 1993, Journal of clinical microbiology.

High‐frequency interferon‐γ‐secreting splenocytes specific for murine cytomegalovirus immediate‐early‐1 (IE‐1) peptide 168YPHFMPTNL176 are insufficient to provide complete protection from viral challenge

C. Sweet, P. Ertl, P. Morley, 2003 .

Immunisation of Balb/c mice with severely attenuated murine cytomegalovirus mutants induces protective cellular and humoral immunity

C. Sweet, P. Ertl, P. Morley, 2002, Journal of medical virology.

Technical issues in construction of nucleic acid vaccines.

L. Thomsen, P. Ertl, 2003, Methods.

Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination.

L. Thomsen, J. Heeney, B. Wahrén, 2008, The Journal of general virology.